116 related articles for article (PubMed ID: 21359197)
1. Overexpression of nuclear protein kinase CK2 α catalytic subunit (CK2α) as a poor prognosticator in human colorectal cancer.
Lin KY; Tai C; Hsu JC; Li CF; Fang CL; Lai HC; Hseu YC; Lin YF; Uen YH
PLoS One; 2011 Feb; 6(2):e17193. PubMed ID: 21359197
[TBL] [Abstract][Full Text] [Related]
2. Intracellular localization of CK2α as a prognostic factor in invasive breast carcinomas.
Homma MK; Kiko Y; Hashimoto Y; Nagatsuka M; Katagata N; Masui S; Homma Y; Nomizu T
Cancer Sci; 2021 Feb; 112(2):619-628. PubMed ID: 33164285
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rh1, a novel casein kinase II subunit alpha (CK2α) inhibitor, retards metastasis via disrupting HHEX/CCL20 signaling cascade involved in tumor cell extravasation across endothelial barrier.
Zheng W; Shen P; Yu C; Tang Y; Qian C; Yang C; Gao M; Wu Y; Yu S; Tang W; Wan G; Wang A; Lu Y; Zhao Y
Pharmacol Res; 2023 Dec; 198():106986. PubMed ID: 37944834
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle-dependent gene networks for cell proliferation activated by nuclear CK2α complexes.
Homma MK; Nakato R; Niida A; Bando M; Fujiki K; Yokota N; Yamamoto S; Shibata T; Takagi M; Yamaki J; Kozuka-Hata H; Oyama M; Shirahige K; Homma Y
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37907238
[TBL] [Abstract][Full Text] [Related]
5. Hybrid-DIA: intelligent data acquisition integrates targeted and discovery proteomics to analyze phospho-signaling in single spheroids.
Martínez-Val A; Fort K; Koenig C; Van der Hoeven L; Franciosa G; Moehring T; Ishihama Y; Chen YJ; Makarov A; Xuan Y; Olsen JV
Nat Commun; 2023 Jun; 14(1):3599. PubMed ID: 37328457
[TBL] [Abstract][Full Text] [Related]
6. Cancer Stem Cell and Aggressiveness Traits Are Promoted by Stable Endothelin-Converting Enzyme-1c in Glioblastoma Cells.
Niechi I; Erices JI; Carrillo-Beltrán D; Uribe-Ojeda A; Torres Á; Rocha JD; Uribe D; Toro MA; Villalobos-Nova K; Gaete-Ramírez B; Mingo G; Owen GI; Varas-Godoy M; Jara L; Aguayo F; Burzio VA; Quezada-Monrás C; Tapia JC
Cells; 2023 Feb; 12(3):. PubMed ID: 36766848
[TBL] [Abstract][Full Text] [Related]
7. In silico investigations identified Butyl Xanalterate to competently target CK2α (CSNK2A1) for therapy of chronic lymphocytic leukemia.
Alsagaby SA; Iqbal D; Ahmad I; Patel H; Mir SA; Madkhali YA; Oyouni AAA; Hawsawi YM; Alhumaydhi FA; Alshehri B; Alturaiki W; Alanazi B; Mir MA; Al Abdulmonem W
Sci Rep; 2022 Oct; 12(1):17648. PubMed ID: 36271116
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase CK2 - diverse roles in cancer cell biology and therapeutic promise.
Trembley JH; Kren BT; Afzal M; Scaria GA; Klein MA; Ahmed K
Mol Cell Biochem; 2023 Apr; 478(4):899-926. PubMed ID: 36114992
[TBL] [Abstract][Full Text] [Related]
9. The Role of Protein Kinase CK2 in Development and Disease Progression: A Critical Review.
Halloran D; Pandit V; Nohe A
J Dev Biol; 2022 Jul; 10(3):. PubMed ID: 35997395
[TBL] [Abstract][Full Text] [Related]
10. CK2β Is a Gatekeeper of Focal Adhesions Regulating Cell Spreading.
Filhol O; Hesse AM; Bouin AP; Albigès-Rizo C; Jeanneret F; Battail C; Pflieger D; Cochet C
Front Mol Biosci; 2022; 9():900947. PubMed ID: 35847979
[TBL] [Abstract][Full Text] [Related]
11. A New Nomogram for Predicting the Postoperative Overall Survival in Patients with Middle-Aged and Elderly Rectal Cancer: A Single Center Retrospective Study in Chinese Population.
Zheng H; Li Z; Zheng S; Li J; Yang J; Zhao E
Int J Gen Med; 2022; 15():5197-5209. PubMed ID: 35651674
[TBL] [Abstract][Full Text] [Related]
12. Validation of an LC-MS/MS Method for the Quantification of the CK2 Inhibitor Silmitasertib (CX-4945) in Human Plasma.
Schwarz R; Richter A; Ito ERD; Murua Escobar H; Junghanß C; Hinz B
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458589
[TBL] [Abstract][Full Text] [Related]
13. High Expression of Casein Kinase 2 Alpha Is Responsible for Enhanced Phosphorylation of DNA Mismatch Repair Protein MLH1 and Increased Tumor Mutation Rates in Colorectal Cancer.
Ulreich K; Firnau MB; Tagscherer N; Beyer S; Ackermann A; Plotz G; Brieger A
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326704
[TBL] [Abstract][Full Text] [Related]
14. Identification of high protein kinase CK2α in HPV(+) oropharyngeal squamous cell carcinoma and correlation with clinical outcomes.
Trembley JH; Li B; Kren BT; Peltola J; Manivel J; Meyyappan D; Gravely A; Klein M; Ahmed K; Caicedo-Granados E
PeerJ; 2021; 9():e12519. PubMed ID: 34993017
[TBL] [Abstract][Full Text] [Related]
15. CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway.
Hussein UK; Ahmed AG; Song Y; Kim KM; Moon YJ; Ahn AR; Park HS; Ahn SJ; Park SH; Kim JR; Jang KY
Cells; 2021 Jul; 10(7):. PubMed ID: 34359939
[TBL] [Abstract][Full Text] [Related]
16. ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis.
Yu H; Yang X; Tang J; Si S; Zhou Z; Lu J; Han J; Yuan B; Wu Q; Lu Q; Yang H
Mol Ther Nucleic Acids; 2021 Mar; 23():27-41. PubMed ID: 33376625
[TBL] [Abstract][Full Text] [Related]
17. Stress granules in colorectal cancer: Current knowledge and potential therapeutic applications.
Legrand N; Dixon DA; Sobolewski C
World J Gastroenterol; 2020 Sep; 26(35):5223-5247. PubMed ID: 32994684
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of Endothelin-Converting Enzyme-1c at Serines 18 and 20 by CK2 Promotes Aggressiveness Traits in Colorectal Cancer Cells.
Pérez-Moreno P; Quezada-Meza C; Chavez-Almarza C; Niechi I; Silva-Pavez E; Trigo-Hidalgo C; Aguayo F; Jara L; Cáceres-Verschae A; Varas-Godoy M; Díaz VM; García de Herreros A; Burzio VA; Tapia JC
Front Oncol; 2020; 10():1004. PubMed ID: 32850305
[TBL] [Abstract][Full Text] [Related]
19. Protein Kinase CK2 in Cancer Energetics.
Silva-Pavez E; Tapia JC
Front Oncol; 2020; 10():893. PubMed ID: 32626654
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-converting enzyme-1c promotes stem cell traits and aggressiveness in colorectal cancer cells.
Pérez-Moreno P; Indo S; Niechi I; Huerta H; Cabello P; Jara L; Aguayo F; Varas-Godoy M; Burzio VA; Tapia JC
Mol Oncol; 2020 Feb; 14(2):347-362. PubMed ID: 31788944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
